Edgar García‐Rill

High Impact

Prefoessor and Director, Center for Translational Neuroscience

UAMS primary UA Little Rock University of Arkansas

Also affiliated: California Institute of Technology (1974); Centre National de la Recherche Scientifique (2016); Arkansas Children's Hospital (2008); Allen Institute for Brain Science (1979–1980); Centre for Addiction and Mental Health (2016); Radboud University Nijmegen (2016); Inserm (2016); University of California, Los Angeles (1974–1987); Université Joseph Fourier (2016); Universidad de Buenos Aires (2019); Commissariat à l'Énergie Atomique et aux Énergies Alternatives (2016); University of Arkansas Medical Center (2016); Asante Three Rivers Medical Center (2007); Centre Hospitalier Universitaire de Grenoble (2016); Radboud University Medical Center (2016); CEA Grenoble (2016); Sorbonne Université (2016); University of Chicago (1977–1980); Central Arkansas Veterans Healthcare System (2007); NeuroDevelopment Center (2011); VA Pacific Islands Health Care System (2005); Administración Nacional de Laboratorios e Institutos de Salud (2019); Klinik und Poliklinik für Psychiatrie und Psychotherapie (1974); Institut du Cerveau (2016); University College London (2016); McGill University (1971–1974); Oklahoma State University Center for Health Sciences (1974)

Faculty Researcher

52 h-index 287 pubs 9,709 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Edgar García‐Rill studies neurological disorders and their treatments, with a focus on sleep-wake phenomena and conditions like tinnitus and Parkinson's disease. His research investigates the effects of interventions such as deep brain stimulation and modafinil. García‐Rill also explores changes in brain activity, including EEG patterns, associated with these conditions and their treatment outcomes. He has published work on these topics, contributing to the understanding of brain function and therapeutic approaches.

Metrics

h-index: 52
Publications: 287
Citations: 9,709

Selected Publications

Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease (2025)

DOI OpenAlex
Contributors (2021)

DOI OpenAlex
Deep brain stimulation for understanding the sleep-wake phenomena (2021)

DOI OpenAlex
Change in EEG Activity is Associated with a Decrease in Tinnitus Awareness after rTMS. (2021)

PubMed 6 citations OpenAlex
Differential effects of HDAC inhibitors on PPN oscillatory activity in vivo (2019)

Neuropharmacology 7 citations DOI OpenAlex
The pedunculopontine nucleus: From posture and locomotion to neuroepigenetics (2019)

AIMS neuroscience 13 citations DOI OpenAlex
The critical role of persistent sodium current in hippocampal gamma oscillations (2019)

Neuropharmacology 11 citations DOI OpenAlex
Proteomic measures of gamma oscillations (2019)

Heliyon 8 citations DOI OpenAlex
Focus on the pedunculopontine nucleus. Consensus review from the May 2018 brainstem society meeting in Washington, DC, USA (2019)

Clinical Neurophysiology 64 citations DOI OpenAlex
Neuroepigenetics of arousal: Gamma oscillations in the pedunculopontine nucleus (2019)

Journal of Neuroscience Research 6 citations DOI OpenAlex
HDAC superfamily promoters acetylation is differentially regulated by modafinil and methamphetamine in the mouse medial prefrontal cortex (2019)

Addiction Biology 21 citations DOI OpenAlex
Impaired step‐length setting prior to turning in Parkinson's disease patients with freezing of gait (2018)

Movement Disorders 27 citations DOI OpenAlex
Bottom‐up gamma and bipolar disorder, clinical and neuroepigenetic implications (2018)

Bipolar Disorders 12 citations DOI OpenAlex
The Critical Role of Intrinsic Membrane Oscillations (2018)

Neurosignals 14 citations DOI OpenAlex
Class II histone deacetylases require P/Q-type Ca2+ channels and CaMKII to maintain gamma oscillations in the pedunculopontine nucleus (2018)

Scientific Reports 17 citations DOI OpenAlex